Symann M - Search Results

1

[Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer].

Symann M, Humblet Y, Bosly A. Symann M, et al. Bull Mem Acad R Med Belg. 1989;144(3-4):213-21; discussion 222-3. Bull Mem Acad R Med Belg. 1989. PMID: 2553180 Clinical Trial. French.

2

Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.

Humblet Y, Feyens AM, Sekhavat M, Agaliotis D, Canon JL, Symann ML. Humblet Y, et al. Among authors: symann ml. Cancer Res. 1989 Sep 15;49(18):5058-61. Cancer Res. 1989. PMID: 2548708

3

Recombinant human interleukin-2 restores in vitro T-cell colony formation by peripheral blood mononuclear cells after autologous bone marrow transplantation.

Bosly AE, Staquet PJ, Doyen CM, Chatelain BJ, Humblet YP, Symann ML. Bosly AE, et al. Among authors: symann ml. Exp Hematol. 1987 Nov;15(10):1048-54. Exp Hematol. 1987. PMID: 3311785

4

Autologous peripheral blood stem cell transplantation for lung cancer.

Guillaume T, Rubinstein DB, Zaner KS, Humblet Y, Symann M. Guillaume T, et al. Among authors: symann m. Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):233-46. doi: 10.1053/beha.1999.0020. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 11000996 Review.

5

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M. Bosly A, et al. Among authors: symann m. Exp Hematol. 1992 Sep;20(8):962-8. Exp Hematol. 1992. PMID: 1354620

6

Biology of small cell lung cancer: an overview.

Weynants P, Humblet Y, Canon JL, Symann M. Weynants P, et al. Among authors: symann m. Eur Respir J. 1990 Jun;3(6):699-714. Eur Respir J. 1990. PMID: 2165919 Review.

7

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC).

Weynants P, Humblet Y, Bosly A, Schallier D, Duprez P, Majois F, Beauduin M, Prignot J, Symann M. Weynants P, et al. Among authors: symann m. Med Oncol Tumor Pharmacother. 1990;7(4):219-22. doi: 10.1007/BF02987098. Med Oncol Tumor Pharmacother. 1990. PMID: 2178205

8

Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease.

Bosly A, Brice P, Humblet Y, Doyen C, Faille A, Chatelain B, Franks C, Gisselbrecht C, Symann M. Bosly A, et al. Among authors: symann m. Nouv Rev Fr Hematol (1978). 1990;32(1):13-6. Nouv Rev Fr Hematol (1978). 1990. PMID: 2349079

9

Immune reconstitution after bone-marrow transplantation.

Symann M, Bosly A, Gisselbrecht C, Brice P, Franks C. Symann M, et al. Cancer Treat Rev. 1989 Jun;16 Suppl A:15-9. doi: 10.1016/0305-7372(89)90018-2. Cancer Treat Rev. 1989. PMID: 2670211 Review.

10

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.

Humblet Y, Symann M, Bosly A, Delaunois L, Francis C, Machiels J, Beauduin M, Doyen C, Weynants P, Longueville J, et al. Humblet Y, et al. Among authors: symann m. J Clin Oncol. 1987 Dec;5(12):1864-73. doi: 10.1200/JCO.1987.5.12.1864. J Clin Oncol. 1987. PMID: 2824708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters